World's largest meeting dedicated to osteoporosis and osteoarthritis opens in Rome

April 17, 2013

The world's largest congress dedicated to the epidemiology, pathogenesis, prevention, and treatment of osteoporosis and osteoarthritis has opened today in Rome, Italy with 4500 delegates.

The European Congress on Osteoporosis & Osteoarthritis (ESCEO13-IOF), which continues until April 20th at the Rome Cavalieri, is jointly organized by the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the International Osteoporosis Foundation (IOF).

ESCEO President Jean-Yves Reginster said, "The Chairs of the Scientific Programme Committee, Professor René Rizzoli and Professor Cyrus Cooper, have planned an extraordinary programme which covers both the latest advances in clinical practice and the most current research in the field. Over the next three days delegates can look forward to hearing about many exciting new developments as well as having the opportunity to meet leading researchers and clinicians from around the world."

Preceded by a special symposium on similarities and differences in osteoporosis and osteoarthritis, ESCEO13-IOF opening ceremony featured an Honorary Lecture on bone deformities in antiquity by Professor Véronique Dasen, followed by the presentation of prestigious awards.

The Congress will continue with eight plenary lectures by leading experts in the bone field, including Ego Seeman, Eric Orwoll, Steffen Gay, Robert E. Coleman, Mary Bouxsein, Eugene McCloskey, Colin Farquharson, and Cyrus Cooper. Eleven special symposia will focus on the latest advances in a wide variety of areas, including treatment, guidelines, vitamin D, quality of life in frailty and sarcopenia, biological markers in osteoarthritis, secondary fracture prevention, and other topics of relevance to every day clinical practice.

Oral and poster presentations from more than 850 submitted abstracts will showcase the latest research in the field. For the first time, 'poster guided tours' will be offered by experts in order to provide special insight into selected key abstracts. The abstracts have been published in the scientific journal 'Osteoporosis International', Volume 24, Supplement 1, 2013.

The joint IOF and ESCEO annual meetings have also become a key forum for translational bone science. The 3rd IOF-ESCEO Pre-Clinical Symposium on April 18, chaired by Professor Anna Teti, will feature eight plenary lectures by key pre-clinical researchers in the area of musculoskeletal disorders.

"Musculokskeletal disorders, including osteoporosis and osteoarthritis, are the second greatest cause of disability worldwide," said IOF President Professor John A. Kanis. "Through this annual congress, IOF and ESCEO are contributing to the advancement of research and health professional knowledge in this important field.

"We hope that the delegates will benefit from the enriching programme, and are able to take home valuable new knowledge that translates into improved care for their patients."
-end-
About IOF

The International Osteoporosis Foundation (IOF) is the world's largest nongovernmental organization devoted to the prevention, diagnosis and treatment of osteoporosis and related diseases of bone, muscles and joints. IOF members, including committees of scientific researchers, patient, medical and research societies, and industry representatives from around the globe, share a common vision of a world without musculoskeletal diseases and fragility fractures. IOF now represents more than 200 societies in all regions of the world. http://www.iofbonehealth.org

About ESCEO

The European Society for Clinical & Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) is a non-profit organization, dedicated to a close interaction between clinical scientists dealing with rheumatic disorders, pharmaceutical industry developing new compounds in this field, regulators responsible for the registration of such drugs and health policy makers, to integrate the management of osteoporosis and osteoarthritis within the comprehensive perspective of health resources utilization. The objective of ESCEO is to provide practitioners with the latest clinical and economic information, allowing them to organize their daily practice, in an evidence-based medicine perspective, with a cost-conscious perception. http://www.esceo.org

International Osteoporosis Foundation

Related Osteoporosis Articles from Brightsurf:

New opportunities for detecting osteoporosis
Osteoporosis can be detected through low dose computed tomography (LDCT) imaging tests performed for lung cancer screening or other purposes.

Oxytocin can help prevent osteoporosis
In a laboratory experiment with rats, Brazilian researchers succeeded in reversing natural processes associated with aging that lead to loss of bone density and strength.

New strategy against osteoporosis
An international research team has found a new approach that may be able to reduce bone loss in osteoporosis and maintain bone health.

New review on management of osteoporosis in premenopausal women
An IOF and ECTS Working Group have published an updated review of literature published after 2017 on premenopausal osteoporosis.

Cardiac CT can double as osteoporosis test
Cardiac CT exams performed to assess heart health also provide an effective way to screen for osteoporosis, potentially speeding treatment to the previously undiagnosed, according to a new study.

Osteoporosis treatment may also protect against pneumonia
A recent study published in the Journal of Bone and Mineral Research found that nitrogen-containing bisphosphonates (N-BPs) such as alendronate, which are widely used to treat postmenopausal osteoporosis, are linked with lower risks of pneumonia and of dying from pneumonia.

New pharmaceutical target reverses osteoporosis in mice
Biomedical engineers at Duke University have discovered that an adenosine receptor called A2B can be pharmaceutically activated to reverse bone degradation caused by osteoporosis in mouse models of the disease.

A link between mitochondrial damage and osteoporosis
In healthy people, a tightly controlled process balances out the activity of osteoblasts, which build bone, and osteoclasts, which break it down.

Many stroke patients not screened for osteoporosis, despite known risks
Many stroke survivors have an increased risk of osteoporosis, falls or breaks when compared to healthy people.

Many postmenopausal women do not receive treatment for osteoporosis
The benefits of treating osteoporosis in postmenopausal women outweigh the perceived risks, according to a Clinical Practice Guideline issued today by the Endocrine Society.

Read More: Osteoporosis News and Osteoporosis Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.